CHUL
2705, boulevard Laurier
R-0755
Québec, QC
Canada G1V 4G2

Dernières nouvelles

Information non disponible

340 enregistrements « 1 de 34 »

Perofsky AC, Huddleston J, Hansen C, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C

Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States

Article de revue

medRxiv, 2024.

Résumé | Liens:

Perofsky AC, Huddleston J, Hansen CL, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C

Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States

Article de revue

Elife, 13 , 2024.

Résumé | Liens:

Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, McDonald E, Nicholson S, Perrett KP, Pittet LF, Rudraraju R, Stevens NE, Subbarao K, Curtis N,

Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial

Article de revue

EBioMedicine, 103 , 2024.

Résumé | Liens:

Houghton MJ, Balland E, Gartner MJ, Thomas BJ, Subbarao K, Williamson G

The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells

Article de revue

Biofactors, 2024.

Résumé | Liens:

Adair A, Tan LL, Feng J, Girkin J, Bryant N, Wang M, Mordant F, Chan L-J, Bartlett NW, Subbarao K, Pymm P, Tham W-H

Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection

Article de revue

J Virol, 98 (6), 2024.

Résumé | Liens:

Griffin DWJ, Dymock M, Wong G, Morrissey CO, Lewin SR, Cheng AC, Howard K, Marsh JA, Subbarao K, Hagenauer M, Roney J, Cunningham A, Snelling T, McMahon JH

Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial

Article de revue

Trials, 25 (1), 2024.

Résumé | Liens:

Vanslambrouck JM, Neil JA, Rudraraju R, Mah S, Tan KS, Groenewegen E, Forbes TA, Karavendzas K, Elliott DA, Porrello ER, Subbarao K, Little MH

Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection

Article de revue

J Virol, 98 (3), 2024.

Résumé | Liens:

Deliyannis G, Gherardin NA, Wong CY, Grimley SL, Cooney JP, Redmond SJ, Ellenberg P, Davidson KC, Mordant FL, Smith T, Gillard M, Lopez E, McAuley J, Tan CW, Wang JJ, Zeng W, Littlejohn M, Zhou R, Fuk-Woo Chan J, Chen ZW, Hartwig AE, Bowen R, Mackenzie JM, Vincan E, Torresi J, Kedzierska K, Pouton CW, Gordon TP, Wang LF, Kent SJ, Wheatley AK, Lewin SR, Subbarao K, Chung AW, Pellegrini M, Munro T, Nolan T, Rockman S, Jackson DC, Purcell DFJ, Godfrey DI

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine

Article de revue

EBioMedicine, 92 , 2023.

Résumé | Liens:

Liu Y, Sánchez-Ovando S, Carolan L, Dowson L, Khvorov A, Jessica Hadiprodjo A, Tseng YY, Delahunty C, Khatami A, Macnish M, Dougherty S, Hagenauer M, Riley KE, Jadhav A, Harvey J, Kaiser M, Mathew S, Hodgson D, Leung V, Subbarao K, Cheng AC, Macartney K, Koirala A, Marshall H, Clark J, Blyth CC, Wark P, Kucharski AJ, Sullivan SG, Fox A

Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines

Article de revue

Vaccine, 41 (48), 2023.

Résumé | Liens:

Barrios MH, Nicholson S, Bull RA, Martinello M, Rawlinson W, Mina M, Post JJ, Hudson B, Gilroy N, Lloyd AR, Konecny P, Mordant F, Catton M, Subbarao K, Caly L, Druce J, Netter HJ

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Article de revue

Microorganisms, 11 (8), 2023.

Résumé | Liens:

340 enregistrements « 1 de 34 »
Signaler des ajouts ou des modifications

Projets actifs

  • Aerosol Infection Research: Better mOdels to Reduce iNdoor Exposure (AIRBORNE), du 2022-06-01 au 2025-05-30
  • Chaire d’excellence de recherche du Canada on Biology and Control of Zoonotic and Pandemic Respiratory Viruses, du 2023-09-01 au 2033-05-26
  • Fond de démarrage-Nouveau chercheur, du 2024-05-27 au 2027-03-31
  • Is treatment with a combination of licensed influenza antivirals superior to monotherapy for highly pathogenic H5N1 influenza virus from cattle?, du 2024-09-01 au 2025-08-31
Information provenant du registre des projets de recherche de l'Université Laval